CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-31 | Delfini Lisa Chief Financial Officer | Grant or award · Performance Stock Option (right to buy) | +72,000 | 110,400 | ||
| 2025-03-10 | Delfini Lisa Chief Financial Officer | Grant or award · Performance Stock Option (right to buy) | +38,400 | 38,400 | ||
| 2025-02-18 | Delfini Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +225,500 | 225,500 | ||
| 2025-01-08 | Delfini Lisa Chief Financial Officer | Option exercise | +5,000 | $0.51 | $3K | 64,660 |
| 2025-01-08 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,000 | 42,125 | ||
| 2025-01-07 | Delfini Lisa Chief Financial Officer | Option exercise | +1,000 | $0.51 | $511 | 59,660 |
| 2025-01-07 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) | −1,000 | 47,125 | ||
| 2024-05-22 | Delfini Lisa Chief Financial Officer | Option exercise | +16,043 | $0.51 | $8K | 57,629 |
| 2024-05-22 | Delfini Lisa Chief Financial Officer | Sale | −4,350 | $2.64 | $11K | 53,279 |
| 2024-05-22 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) | −16,043 | 48,125 | ||
| 2024-02-15 | Delfini Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2023-10-11 | Delfini Lisa Chief Financial Officer | Option exercise 10b5-1 | +2,292 | $0.51 | $1K | 36,686 |
| 2023-10-11 | Delfini Lisa Chief Financial Officer | Sale 10b5-1 | −785 | $2.02 | $2K | 35,901 |
| 2023-10-11 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,292 | 64,168 | ||
| 2023-09-11 | Delfini Lisa Chief Financial Officer | Option exercise 10b5-1 | +2,291 | $0.51 | $1K | 35,105 |
| 2023-09-11 | Delfini Lisa Chief Financial Officer | Sale 10b5-1 | −711 | $2.20 | $2K | 34,394 |
| 2023-09-11 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,291 | 66,460 | ||
| 2023-08-11 | Delfini Lisa Chief Financial Officer | Option exercise 10b5-1 | +2,292 | $0.51 | $1K | 33,496 |
| 2023-08-11 | Delfini Lisa Chief Financial Officer | Sale 10b5-1 | −682 | $2.36 | $2K | 32,814 |
| 2023-08-11 | Delfini Lisa Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,292 | 68,751 |
Page 1 of 3 · 41 trades